Carfilzomib

Product name:Carfilzomib
CAS: 868540-17-4
Molecular Formula: C40H57N5O7
Molecular weight:719.9099
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Carfilzomib is an anti-cancer drug acting as a selective proteasome inhibitor.For use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.